95 related articles for article (PubMed ID: 25563560)
1. Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.
El-Galaly TC; Bilgrau AE; Gaarsdal E; Klausen TW; Pedersen LM; Nielsen KR; Bæch J; Bøgsted M; Dybkær K; Johansen JS; Johnsen HE
Leuk Lymphoma; 2015; 56(8):2476-8. PubMed ID: 25563560
[No Abstract] [Full Text] [Related]
2. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis.
Imai Y; Aochi S; Iwatsuki K; Sano H; Yamanishi K
J Dermatol; 2013 Apr; 40(4):294-6. PubMed ID: 23397985
[No Abstract] [Full Text] [Related]
3. YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Hottinger AF; Iwamoto FM; Karimi S; Riedel E; Dantis J; Park J; Panageas KS; Lassman AB; Abrey LE; Fleisher M; Holland EC; DeAngelis LM; Hormigo A
Ann Neurol; 2011 Jul; 70(1):163-9. PubMed ID: 21391238
[TBL] [Abstract][Full Text] [Related]
4. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects.
Nielsen AR; Plomgaard P; Krabbe KS; Johansen JS; Pedersen BK
Cytokine; 2011 Jul; 55(1):152-5. PubMed ID: 21478032
[TBL] [Abstract][Full Text] [Related]
5. Disease indicators for sepsis and analysis of sepsis treatment in children using the continuous blood purification technique.
Liu JP; Wang XW; Qie LP
Genet Mol Res; 2015 May; 14(2):5685-93. PubMed ID: 26125767
[TBL] [Abstract][Full Text] [Related]
6. Could YKL-40 be used as a new marker for coronary artery ectasia?
Kim BJ
Anadolu Kardiyol Derg; 2013 Aug; 13(5):471-2. PubMed ID: 23728271
[No Abstract] [Full Text] [Related]
7. Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.
Biggar RJ; Johansen JS; Smedby KE; Rostgaard K; Chang ET; Adami HO; Glimelius B; Molin D; Hamilton-Dutoit S; Melbye M; Hjalgrim H
Clin Cancer Res; 2008 Nov; 14(21):6974-8. PubMed ID: 18980992
[TBL] [Abstract][Full Text] [Related]
8. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of some inflammatory markers in patients with multiple sclerosis.
Uysal S; Meriç Yilmaz F; Boğdaycioğlu N; Mungan Öztürk S; Ak F
Minerva Med; 2014 Jun; 105(3):229-35. PubMed ID: 24988088
[TBL] [Abstract][Full Text] [Related]
10. YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis.
Imai Y; Tsuda T; Aochi S; Futatsugi-Yumikura S; Sakaguchi Y; Nakagawa N; Iwatsuki K; Yamanishi K
J Dermatol Sci; 2011 Oct; 64(1):75-7. PubMed ID: 21782391
[No Abstract] [Full Text] [Related]
11. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease.
Wu S; Hsu LA; Cheng ST; Teng MS; Yeh CH; Sun YC; Huang HL; Ko YL
Int J Mol Sci; 2014 Dec; 15(12):22421-37. PubMed ID: 25486056
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies.
Cheng D; Sun Y; He H
Med Oncol; 2014 Dec; 31(12):326. PubMed ID: 25412935
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 levels are correlated with symptom severity in patients with allergic rhinitis.
Kwon JW; Kim TW; Cho SH; Min KU; Park HW
Allergy; 2011 Sep; 66(9):1252-3. PubMed ID: 21480926
[No Abstract] [Full Text] [Related]
16. Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?
Matusiak Ł; Salomon J; Nowicka-Suszko D; Bieniek A; Szepietowski JC
Acta Derm Venereol; 2015 Jul; 95(6):736-7. PubMed ID: 25655759
[No Abstract] [Full Text] [Related]
17. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
Jiang YX; Zhang GH; Wang ZM; Yang H
Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of YKL-40 concentrations in nonmyeloablative conditioning allogeneic hematopoietic cell transplantation.
Mørup AM; Kornblit B; Johansen JS; Masmas TN; Madsen HO; Vindeløv L; Garred P
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1299-307. PubMed ID: 21232622
[TBL] [Abstract][Full Text] [Related]
19. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
